Myorelaxant effect of bee venom topical skin application in patients with RDC/TMD Ia and RDC/TMD Ib: a randomized, double blinded study.
Aleksandra Nitecka-BuchtaPiotr BuchtaElżbieta Tabeńska-BosakowskaKarolina Walczyńska-DragonStefan BaronPublished in: BioMed research international (2014)
The aim of the study was the evaluation of myorelaxant action of bee venom (BV) ointment compared to placebo. Parallel group, randomized double blinded trial was performed. Experimental group patients were applying BV for 14 days, locally over masseter muscles, during 3-minute massage. Placebo group patients used vaseline for massage. Muscle tension was measured twice (TON1 and TON2) in rest muscle tonus (RMT) and maximal muscle contraction (MMC) on both sides, right and left, with Easy Train Myo EMG (Schwa-medico, Version 3.1). Reduction of muscle tonus was statistically relevant in BV group and irrelevant in placebo group. VAS scale reduction was statistically relevant in both groups: BV and placebo. Physiotherapy is an effective method for myofascial pain treatment, but 0,0005% BV ointment gets better relief in muscle tension reduction and analgesic effect. This trial is registered with Clinicaltrials.gov NCT02101632.
Keyphrases
- phase iii
- skeletal muscle
- end stage renal disease
- double blind
- lipopolysaccharide induced
- lps induced
- newly diagnosed
- clinical trial
- open label
- phase ii
- study protocol
- peritoneal dialysis
- chronic pain
- patient reported outcomes
- mass spectrometry
- heart rate
- wound healing
- anti inflammatory
- body composition
- upper limb
- smooth muscle